Pharmstandard To Pay $590M For Pharmaceutical Supply Co.
Russian drugmaker Pharmstandard plans to buy Bever Pharmaceutical, the supplier of ingredients for its two flagship drugs, for $590 million as part of a plan to spin off its over-the-counter business,...To view the full article, register now.
Already a subscriber? Click here to view full article